CAS RN: 1132935-63-7

ABT-333

Product Availability

Choose a grade to view its available package options.

9 package records5 with current stock3 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250201 10mg / 50mg / 100mg Confirm by inquiry Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260525 100mg Out of stock Inquiry
Batchno.20250430 1g Out of stock Inquiry
Batchno.20260314 250mg Out of stock Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260114 100mg Out of stock Inquiry
Batchno.20251030 10mg In stock Inquiry
Batchno.20251003 25mg In stock Inquiry
Batchno.20250224 50mg In stock Inquiry
Batchno.20260520 5mg In stock Inquiry
  • Product code: starshine_CAS1132935-63-7
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1132935-63-7 / N-[6-[3-tert-butyl-5-(2,4-dioxopyrimidin-1-yl)-2-methoxyphenyl]naphthalen-2-yl]methanesulfonamide

Dasabuvir | ABT-333 | ABT333

Standard CAS: 1132935-63-7 Multi CAS: Yes

Basic Information

CAS
1132935-63-7
Multi CAS
Yes
Molecular Formula
C26H27N3O5S
Molecular Weight
493.600000
Exact Mass
493.167142
SMILES
CC(C)(C)C1=CC(=CC(=C1OC)C2=CC3=C(C=C2)C=C(C=C3)NS(=O)(=O)C)N4C=CC(=O)NC4=O
InChI
InChI=1S/C26H27N3O5S/c1-26(2,3)22-15-20(29-11-10-23(30)27-25(29)31)14-21(24(22)34-4)18-7-6-17-13-19(28-35(5,32)33)9-8-16(17)12-18/h6-15,28H,1-5H3,(H,27,30,31)
InChIKey
NBRBXGKOEOGLOI-UHFFFAOYSA-N
Synonyms
Dasabuvir ABT-333 ABT333 exviera N-(6-(3-tert-Butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide

Computed Properties

Structural Parameters

Heavy atom count
35
Aromatic heavy atom count
22
Fraction Csp3
0.23
Rotatable bonds
5
H-bond acceptors
6
H-bond donors
2
Molar refractivity
139.32
TPSA
110.26

LogP / Solubility

WLOGP
4.02
MLOGP
3.58
XLogP3
4.3
Consensus LogP
3.97
Log S (ESOL)
-5.57
Class (ESOL)
Slightly soluble
Log S (Ali)
-6.51
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-6.81
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.87

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
3

Safety & Transport

GHS Hazard Statements
H413 (100%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard]
Precautionary Statement Codes
P273, and P501

Get In Touch

Contact Us